| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/16/2009 | WO2009089338A2 Method and compositions for administering resveratrol and pterostilbene |
| 07/16/2009 | WO2009089070A2 Compositions and methods for reducing particle penetration through mucus |
| 07/16/2009 | WO2009089011A2 Resveratrol formulations |
| 07/16/2009 | WO2009088959A1 Enhanced delivery of antifungal agents |
| 07/16/2009 | WO2009088891A1 Screening method for selected amino lipid-containing compositions |
| 07/16/2009 | WO2009088826A1 Liquid antiseptic compositions containing iodine and a sugar and/or sugar alcohol |
| 07/16/2009 | WO2009088777A1 Article and method for focused delivery of therapeutic and/or diagnostic materials |
| 07/16/2009 | WO2009088673A2 Pharmaceutical composition |
| 07/16/2009 | WO2009088553A1 Dry powder drug delivery formulations, methods of use, and devices therefore |
| 07/16/2009 | WO2009088385A1 Resin-complex granulation for water-soluble drugs and associated methods |
| 07/16/2009 | WO2009088319A1 Magnetic polymer granules and a method for forming a locking gel plug |
| 07/16/2009 | WO2009088318A1 Magnetic polymer granules and a method for the use thereof |
| 07/16/2009 | WO2009088142A1 Transdermal drug delivery system containing granisetron |
| 07/16/2009 | WO2009087987A1 Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly |
| 07/16/2009 | WO2009087938A1 Capsule formulation |
| 07/16/2009 | WO2009087690A2 Multiparticulate extended release pharmaceutical composition of carbamazepine and process for manufacturing the same |
| 07/16/2009 | WO2009087682A2 Stabilized injectable formulation of pregabalin |
| 07/16/2009 | WO2009087678A2 Nanodispersion |
| 07/16/2009 | WO2009087675A2 Coated extended release pharmaceutical compositions of levetiracetam |
| 07/16/2009 | WO2009087665A2 Gastroretentive drug delivery system |
| 07/16/2009 | WO2009087663A2 Oral controlled release coated tablet |
| 07/16/2009 | WO2009087660A1 Stable oxaliplatin composition for parenteral administration |
| 07/16/2009 | WO2009087658A2 Ketorolac tromethamine containing parenteral formulation |
| 07/16/2009 | WO2009087657A2 Stable pharmaceutical composition of duloxetine and process for its preparation |
| 07/16/2009 | WO2009087647A1 A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders |
| 07/16/2009 | WO2009087632A2 Emulsified wax compositions and uses thereof |
| 07/16/2009 | WO2009087485A2 Topical compositions for delivery of proteins and peptides |
| 07/16/2009 | WO2009087410A2 Solid pharmaceutical dosage form |
| 07/16/2009 | WO2009087370A1 Lubricant mousse |
| 07/16/2009 | WO2009087148A2 Analgesic apatitic calcium-phosphate cement |
| 07/16/2009 | WO2009087122A1 Silver nanoparticles with specific surface area and a method for producing them |
| 07/16/2009 | WO2009086942A1 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release |
| 07/16/2009 | WO2009086941A1 Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release |
| 07/16/2009 | WO2009086940A1 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon |
| 07/16/2009 | WO2009086695A1 Use of extractive of bcg polysaccharide and nucleic acid for preparing medicine for treating allergic dermatosis, and its injection and preparation method |
| 07/16/2009 | WO2009086694A1 Use of extractive of bcg polysaccharide and nucleic acid for preparing medicine for treating viral skin diseases, and its injection and preparation method |
| 07/16/2009 | WO2009070210A3 Sustained release of apo a-i mimetic peptides and methods for delivery in situ |
| 07/16/2009 | WO2009070209A3 Sustained release of apo a-i mimetic peptides and methods of producing them |
| 07/16/2009 | WO2009068708A3 Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof |
| 07/16/2009 | WO2009064964A3 Switchable nano-vehicle delivery systems, and methods for making and using them |
| 07/16/2009 | WO2009059701A3 Sustained release tablets with hydromorphone |
| 07/16/2009 | WO2009058950A3 Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide |
| 07/16/2009 | WO2009058005A3 Unit dosage for brain health |
| 07/16/2009 | WO2009048958A3 Methods and compositions involving chitosan nanoparticles |
| 07/16/2009 | WO2009046198A3 Sustained delivery of compstatin analogs from gels |
| 07/16/2009 | WO2009045795A3 Galenical formulations of aliskiren and valsartan |
| 07/16/2009 | WO2009027561A3 Oral pharmaceutical desmopressin composition |
| 07/16/2009 | WO2009011584A3 A method of preparing a pharmaceutical co-crystal composition |
| 07/16/2009 | WO2009000216A3 A rupturing controlled release device comprising a subcoat |
| 07/16/2009 | WO2008146016A3 Cyclodextrins for administering fatty acids in tablets |
| 07/16/2009 | WO2008141751A3 Pharmaceutical compositions comprising oxcarbazepine |
| 07/16/2009 | WO2008130587A3 Solvent-cast microneedle arrays containing active |
| 07/16/2009 | WO2008115811A4 Transdermal delivery form disposal systems and methods |
| 07/16/2009 | WO2008100576A3 Sustained delivery formulations of rapamycin compounds |
| 07/16/2009 | WO2008079464A8 Stable powder formulations of alum-adsorbed vaccines |
| 07/16/2009 | WO2008076287A4 Methods of making pharmaceutical components for customized drug products |
| 07/16/2009 | WO2008058220A3 Transdermal drug delivery system |
| 07/16/2009 | WO2008058074A3 Sugar coatings and methods therefor |
| 07/16/2009 | WO2007098611A8 Compositions for treatment of cancer |
| 07/16/2009 | WO2004055164A3 System and method for stabilizing antibodies with histidine |
| 07/16/2009 | WO2004005430A9 Catalyst for conversion processes |
| 07/16/2009 | WO2002087497A3 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
| 07/16/2009 | US20090182303 Targeted Therapeutic Agent Release for Weight Loss Therapy |
| 07/16/2009 | US20090182062 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090182056 Pharmaceutical formulations of amyloid inhibiting compounds |
| 07/16/2009 | US20090182047 Utilization of dialkylfumarates |
| 07/16/2009 | US20090182024 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 07/16/2009 | US20090181919 Method for Freeze-Drying Nucleic Acid/Block Copolymer/Cationic Surfactant Complexes |
| 07/16/2009 | US20090181895 Stabilised Compositions of Factor VII Polypeptides |
| 07/16/2009 | US20090181191 Capsule for taking an active substance which can be inhaled |
| 07/16/2009 | US20090181101 Nanoparticles comprising antibacterial ligands |
| 07/16/2009 | US20090181100 Dry powder aerosols of Nanoparticulate drugs |
| 07/16/2009 | US20090181099 Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| 07/16/2009 | US20090181098 Hmg-Co-a Reductase Inhibitor Enhancement of Bone and Cartilage |
| 07/16/2009 | US20090181097 Particles |
| 07/16/2009 | US20090181096 Method Of Targeting Sustained Release Formulations Of Therapeutic Agents To Treat Lung Diseases |
| 07/16/2009 | US20090181095 Oxidative stress inhibitor |
| 07/16/2009 | US20090181094 Molecular Cage for Sustained Release Control of Pharmaceutical and Cosmetic Agents |
| 07/16/2009 | US20090181093 Methods for treating soft tissue damage associated with a surgical procedure |
| 07/16/2009 | US20090181092 Methods for Treating Joints and Discs with a Carrier Matrix and Cells |
| 07/16/2009 | US20090181091 Product and process to regulate a gene network involved in constitutive inflammation and early cancer progression |
| 07/16/2009 | US20090181090 Protein-Based Carrier System for Overcoming Resistance in Tumour Cells |
| 07/16/2009 | US20090181089 PH-Controlled Pulsatile Delivery System, Methods for Preparation and Use Thereof |
| 07/16/2009 | US20090181088 Thermosensitive polyphosphazene-bioactive molecule conjugates, preparation method thereof and use thereof |
| 07/16/2009 | US20090181087 Use of human cord blood-derived pluripotent cells for the treatment of disease |
| 07/16/2009 | US20090181086 Rasagiline formulations, their preparation and use |
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/16/2009 | US20090181084 Oral fast-disintegrating tablet including particles of slowly-releaseable ascorbic acid |
| 07/16/2009 | US20090181083 Porous tablets as carriers for liquid formulations |
| 07/16/2009 | US20090181082 Tablet |
| 07/16/2009 | US20090181081 Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance |
| 07/16/2009 | US20090181080 Oral cannabinnoid liquid formulations and methods of treatment |
| 07/16/2009 | US20090181079 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 07/16/2009 | US20090181078 Vaccine composition containing synthetic adjuvant |
| 07/16/2009 | US20090181077 Detection of pkc-iota as a biomarker for brain tumorigenesis |
| 07/16/2009 | US20090181076 Drug Release From Nanoparticle-Coated Capsules |
| 07/16/2009 | US20090181075 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof |
| 07/16/2009 | US20090181073 Method for treating irritation caused by hair removal |
| 07/16/2009 | US20090181069 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090181065 Methods and devices for promoting endothelial morphogenesis |